🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Kuangli Bio-Tech Holdings Co., Ltd. (TPE:6431)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
14.25
-1.05 (-6.86%)
Nov 20, 2026, 1:30 PM CST

Kuangli Bio-Tech Holdings Revenue

Kuangli Bio-Tech Holdings had revenue of 134.86M TWD in the quarter ending September 30, 2026, with 100.19% growth. This brings the company's total for the last twelve months to 430.76M, up 11.20% year-over-year. In the year 2025, Kuangli Bio-Tech Holdings had annual revenue of 377.03M, down -1.12%. That makes Kuangli Bio-Tech Holdings the 36,168th largest company in the world by revenue and 1,879th in Taiwan.

Revenue (ttm)
430.76M
Revenue Growth
+11.20%
P/S Ratio
3.22
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.39B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Biotechnology Segment 335.13M 88.9%
  • Health Management Department 41.90M 11.1%

By Geography

Chart
  • Mainland China 335.13M 88.9%
  • Taiwan 41.90M 11.1%

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025377.03M-4.27M-1.12%
Dec 31, 2024381.30M87.93M29.97%
Dec 31, 2023293.37M-48.79M-14.26%
Dec 31, 2022342.16M9.53M2.86%
Dec 31, 2021332.63M245.66M282.47%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.